Which item is included on the IND application? (to describe studies?)

• A. Clinical protocols for studies to be conducted
• B. Advertising materials to recruit participants
• C. Market authorization letter
• D. Patient payroll records

Answer: (A)

The key idea here is what the FDA requires to describe how human studies will be carried out. In an IND submission, the clinical protocols are included because they lay out the exact plan for each study: study design, dosing regimens, number of participants, inclusion and exclusion criteria, endpoints, randomization or blinding if used, data collection methods, and safety monitoring procedures. This information shows FDA reviewers how the trials will be conducted and how safety will be assessed.

Advertising materials to recruit participants aren’t part of the trial plan itself; they relate to recruitment but don’t describe how the studies will be conducted. A market authorization letter comes later, after the trials and review are complete, and isn’t part of the IND. Patient payroll records are administrative and not related to trial design or regulatory submission.